Infection and Immunotherapy Research Group

The goal of the Infection and Immunotherapy Research (IIR) is to develop new immunotherapies against infectious diseases and cancer. They aim to provide a new translational understanding on HIV cure, bacterial infections and of cancer immunology. The group is also involved in clinical research working towards the elimination of HIV and Hepatitis in Luxembourg.

Aims and objectives

We focus on the development of immunotherapeutic complexes and NK cell engagers boosting innate immunity against viruses, bacteria and cancer cells for further elimination by the immune system. Our research encompasses protein engineering, virology, bacteriology, immunoassays and preclinical studies for the design of targeted therapeutic approaches.

HIV and viral hepatitis elimination

Our group support the monitoring of HIV and Hepatitis elimination in Luxembourg, as part of international research and surveillance networks, through outreach projects and clinical studies from the national HIV and Hepatitis programmes.

Carole
Seguin-Devaux

Projects & clinical trials

Featured team members

  • Carole
    Devaux
    Group Leader and Deputy Head Quality & Safety
  • Gilles
    Iserentant
    Research Engineer
  • Aubin
    Pitiot
    Postdoctoral Fellow
  • Samiha
    Regaia
    Research Engineer
  • Camille
    Rolin
    PhD Student
  • Jean-Yves
    Servais
    Research Engineer

Scientific publications

Related News

Job vacancies

There are no jobs matching this page at the moment. You can view all jobs via the button below.

Make a donation